data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Brainstorm Cell
(NASDAQ:BCLI)
$2.78
00
At close: Jun 29
$2.85
0.0700[2.52%]
PreMarket: 4:53PM EDT
15 minutes delayed
Day High/Low- - -
52 Week High/Low2.65 - 4.46
Open / Close- / -
Float / Outstanding33.7M / 36.5M
Vol / Avg.- / 63.4K
Mkt Cap101.4M
P/E-
50d Avg. Price2.92
Div / Yield-
Payout Ratio-
EPS-0.15
Total Float33.7M

Brainstorm Cell (NASDAQ:BCLI), Quotes and News Summary

Brainstorm Cell (NASDAQ: BCLI)

Day High/Low- - -
52 Week High/Low2.65 - 4.46
Open / Close- / -
Float / Outstanding33.7M / 36.5M
Vol / Avg.- / 63.4K
Mkt Cap101.4M
P/E-
50d Avg. Price2.92
Div / Yield-
Payout Ratio-
EPS-0.15
Total Float33.7M
Benzinga - May 25, 2022, 8:46AM
Benzinga - May 24, 2022, 11:21AM
Benzinga - May 24, 2022, 10:03AM
Benzinga - May 16, 2022, 7:16AM
Benzinga - Apr 4, 2022, 10:20AM
Benzinga - Mar 28, 2022, 7:18AM
Benzinga - Feb 15, 2022, 7:35AM
Benzinga - Dec 27, 2021, 7:02AM
Benzinga - Dec 14, 2021, 2:51PM
Benzinga - Dec 13, 2021, 1:52PM
Benzinga - Dec 13, 2021, 1:11PM
Benzinga - Dec 13, 2021, 1:09PM
Benzinga - Dec 7, 2021, 7:09AM
Benzinga - Nov 29, 2021, 9:35AM
Benzinga - Nov 29, 2021, 7:31AM
Benzinga - Nov 17, 2021, 10:24AM
Benzinga - Nov 17, 2021, 10:24AM
Benzinga - Nov 17, 2021, 10:10AM
Benzinga - Nov 15, 2021, 7:01AM
load more
Sector: Health Care.Industry: Biotechnology
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.130-0.150 -0.0200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Brainstorm Cell Questions & Answers

Q
How do I buy Brainstorm Cell (BCLI) stock?
A

You can purchase shares of Brainstorm Cell (NASDAQ: BCLI) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Brainstorm Cell's (BCLI) competitors?
Q
What is the target price for Brainstorm Cell (BCLI) stock?
A

The latest price target for Brainstorm Cell (NASDAQ: BCLI) was reported by Maxim Group on Friday, February 5, 2021. The analyst firm set a price target for 0.00 expecting BCLI to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Brainstorm Cell (BCLI)?
A

The stock price for Brainstorm Cell (NASDAQ: BCLI) is $2.78 last updated June 29, 2022, 8:00 PM UTC.

Q
Does Brainstorm Cell (BCLI) pay a dividend?
A

There are no upcoming dividends for Brainstorm Cell.

Q
When is Brainstorm Cell (NASDAQ:BCLI) reporting earnings?
A

Brainstorm Cell’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Brainstorm Cell (BCLI) going to split?
A

There is no upcoming split for Brainstorm Cell.

Q
What sector and industry does Brainstorm Cell (BCLI) operate in?
A

Brainstorm Cell is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.